Professional Documents
Culture Documents
By Tessa Rodgers
Epidemiology
Most common primary intraocular tumor in pediatrics
Equally common amongst African Americans/Caucasians &
Females/Males
1 in 15,000 live births in US and Northern Europe
Birth 14 years old
- 95% < 5 years old at diagnosis
1/3 of cases are bilateral
- Younger
Etiology
40% Genetic Mutation
- RB1 tumor suppressor gene (chromosome 13)
- Bilateral
- Multifocal retinoblastoma
- Higher risk of developing secondary malignancy
60% Sporadic
- Unilateral
Staging
Presenting Symptoms
Leukocoria
Strabismus
Glaucoma
Poor vision
Irritability
Failure to eat
Low fever
Metastases
Optic Nerve Brain
Layers of eyeball Eye Socket
Eye Lid
Lymph nodes Liver
Bones
Bone Marrow
Common Treatment
Brachytherapy
- Up to 16 mm in diameter & 8 mm in thickness
- Eye plaque (Gold or Lead)
- Sewn into place
-
Iodine-125
Palladium-103
5 to 7 days
4000 6000 cGy
Cryotherapy
Singular tumors
Up to 4 mm in diameter & 2 mm in thickness
Small metal probe cooled with liquid nitrogen
Probe placed on outer surface of eye directly behind tumor
Frozen and thawed several times
- Creates intracellular crystals causing tumor cells to rupture
2-3 treatments each 1 month apart
Cryotherapy
Temporary swelling of eye and eyelid, damage to retina
resulting in blind spots
My
Personal
Opinion
Aunt Tessa, Im
extremely skeptical
about what treatment I
should choose What do
you think I should do?
BRACHYTHERAPY
Shortest treatment duration
Least amount of times put under anesthesia
Not waiting months to see how tumor responds
References
Abramson DH, Ellsworth RM, Rozakis GW. Cryotherapy for Retinoblastoma. Arch
Ophthalmol. 1982; 100(8): 1253-1256.
Ammiryan ABeiki-Ardakani A, Galllie B. The American Brachytherapy Society
consensus guidelines for plaque brachytherapy of uveal melanoma and
retinoblastoma. Brachytherapy An International Multidisciplinary Journal. 2014;
13(1): 14.
Krengli, Marco et al. Proton radiation therapy for retinoblastoma: Comparison of
various intraocular tumor locations and beam arrangements. International
Journal of Radiation Oncology. 2005; 61(2): 583-593.